Słoneczkosp. j.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2003-03-24
Registered address
Zduny 10, 99-440 Zduny, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed.

  • 2025not filed
  • 202431/03/2025
  • 202309/05/2024
  • 202206/05/2023
  • 202104/05/2022
  • 202008/04/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 2.25mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 208.98kMedianUSD 20.70kAverageUSD 86.70k
Operating costs
This companyUSD 2.03mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 581.04kMedianUSD 543.65kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Słoneczko has been an NFZ healthcare provider since 2024. In 2026 it is performing 2 contracts with a total value of USD 908.75. All its contracts were worth USD 1.88k in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmaciesłódzkie2USD 908.75

Ownership

Owner
Dariusz Gałajage 63
Katarzyna Gałajage 58

Manner of representation

Each partner may independently represent the company.

Dariusz Gałaj and Katarzyna Gałaj – all partners share the same surname, so the structure looks family-owned.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2000-10-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $103,505.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$463
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$91,850
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,703

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Novopharm - Millersp. j.
Pikadasp. z o.o.
Vitasp. z o.o.
Gold Lionsp. z o.o.
Grupa Aptekarska Kujałowiczsp. j.
Herbarium Świętego Franciszkasp. z o.o.
Eurekasp. z o.o.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Awicennasp. j.

Change history

DateEvent
2021-02-12Switch to PKD 2007
2003-03-24Entered in the register

FAQ

Last updated: 2026-03-21